Sydney, May 31, 2007 (ACN Newswire) - On 19 March 2007 Life Therapeutics (ASX: LFE) (PNK: LFEFY) announced that it had entered into a non-binding Heads of Agreement with a European fractionator in relation to a proposed transaction. At that time, the company granted to the European fractionator exclusive negotiation rights up until 1 June 2007.
